Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis

Journal of Clinical Microbiology

Volumn 50, Issue 1, 2012, Pages 199-201

  Verstreken, Isabel ^a   Laleman, Wim ^a   Wauters, Georges ^b   Verhaegen, Jan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Catholic University Hospital Louvain   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; CLARITHROMYCIN; CLINDAMYCIN; COLISTIN; CYCLOSPORIN; ERYTHROMYCIN; GANCICLOVIR; INFLIXIMAB; MEROPENEM; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; TACROLIMUS;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CAMPYLOBACTER; CASE REPORT; COLITIS; COLON BIOPSY; COLONOSCOPY; COMORBIDITY; CONVALESCENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS COLITIS; CYTOMEGALOVIRUS INFECTION; DEHYDRATION; DESULFOVIBRIO DESULFURICANS; DESULFOVIBRIONACEAE INFECTION; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; GRAM STAINING; HEMATOCHEZIA; HUMAN; IMMUNOCOMPROMISED PATIENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MINIMUM INHIBITORY CONCENTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TREATMENT OUTCOME; ULCERATIVE COLITIS;

AGED; BACTEREMIA; COLITIS, ULCERATIVE; DESULFOVIBRIO DESULFURICANS; DESULFOVIBRIONACEAE INFECTIONS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LIVER TRANSPLANTATION;

DESULFOVIBRIO; DESULFOVIBRIO DESULFURICANS; NEGIBACTERIA;

EID: 84555178929     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00987-11     Document Type: Article

References (13)

1. CLSI. 2011. Performance standards for antimicrobial susceptibility testing. M100-S21, vol. 31, no. 1. CLSI, Wayne, PA.
2. .Cummings JH, Macfarlane GT, Macfarlane S. 2003. Intestinal bacteria and ulcerative colitis. Curr. Issues Intest. Microbiol. 4:9-20. (Pubitemid 36442897)
3. Gibson GR, Cummings JH, Macfarlane GT. 1991. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol. Ecol. 86:103-112.
4. Goldstein EJC, Citron DM, Peraino VA, Cross SA. 2003. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J. Clin. Microbiol. 41:2752-2754. (Pubitemid 36712509)
5. Loubinoux J, Mory F, Pereira IAC, Le Faou AE. 2000. Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis. J. Clin. Microbiol. 38:931-934. (Pubitemid 30082717)
6. Lozniewski A, Labia R, Haristoy X, Mory F. 2001. Antimicrobial susceptibilities of clinical Desulfovibrio isolates. Antimicrob. Agents Chemother. 45:2933-2935. (Pubitemid 32906697)
7. McDougall R, Robson J, Paterson D, Tee W. 1997. Bacteremia caused by a recently described novel Desulfovibrio species. J. Clin. Microbiol. 35:1805-1808. (Pubitemid 27255664)
8. Murray PR, et al. (ed). Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
9. Nakao K, et al. 2009. Susceptibilities of 23 Desulfovibrio isolates from humans. Antimicrob. Agents Chemother. 53:5308-5311.
10. Porschen RK, Chan P. 1977. Anaerobic Vibrio-like organisms cultured from blood: Desulfovibrio desulfuricans and Succinivibrio species. J. Clin. Microbiol. 5:444-447.
11. Rowan FE, Docherty NG, Coffey JC, O'Connell PR. 2009. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br. J. Surg. 96:151-158.
12. Warren YA, Citron DM, Merriam CV, Goldstein EJC. 2005. Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera. J. Clin. Microbiol. 43:4041-4045. (Pubitemid 41129697)
13. Wauters G, et al. 2003. Brevibacterium lutescens sp. nov., from human and environmental samples. Int. J. Syst. Evol. Microbiol. 53:1321-1325. (Pubitemid 37184960)